Question
Depolarizing neuromuscular blocking agents
Q19 0.3 marks Short Answers ★ ✓
Answer
Succinylcholine (Suxamethonium) is the only clinically used depolarizing neuromuscular blocker — it binds nicotinic receptors at the motor end-plate and persistently depolarizes the membrane (unlike acetylcholine, it is not rapidly hydrolyzed by acetylcholinesterase), producing initial fasciculations followed by flaccid paralysis; used for rapid-sequence intubation because of its rapid onset and very short duration.
1 Skeletal Muscle Relaxants
Other Years Asked
1 ( 2023 January (Supplementary) (2019 Scheme) Short Essay · 8 marks 2 Read the clinical problem and answer the following questions: 30 years old man was admitted
in emergency ward with acute abdominal pain. After diagnosed with acute appendicitis, he was
taken for surgery. On the operation table, after administration of a skeletal muscle relaxant,
patient developed difficulty in breathing and went in for apnoea. 2015 September (Supplementary) (2010 Scheme) Essay · 6 marks 3 Read the clinical problem and answer the following questions: A 50 years old man was
administered succinylcholine for endotracheal intubation. The patient developed
prolonged muscle paralysis and apnea. (2+2+2)
What could be the cause of apnea in this patient
How will you treat the apnea
Name two muscle relaxants that you can use in this patient in future 2021 May (Supplementary) (2010 Scheme) Essay · 6 marks 4 Atracurium 2020 February (Supplementary) (2010 Scheme) Short Note · 3 marks 5 Mechanism of action of diazepam 2014 March (2010 Scheme) Short Answer · 1 mark 6 Mechanism of action of pancuronium. 2016 October (Supplementary) (2010 Scheme) Short Answer · 1 mark 7 Diazepam 2023 March (Supplementary) (2010 Scheme) Short Answer · 1 mark 8 Flumazenil 2013 April (2010 Scheme) Short Answer · 1 mark 9 Centrally acting muscle relaxants 2015 September (Supplementary) (2010 Scheme) Short Answer · 1 mark 10 Mechanism of action of diazepam. 2016 February (2010 Scheme) Short Answer · 1 mark 11 Mechanism of action of dantrolene sodium. 2014 September (Supplementary) (2010 Scheme) Short Answer · 1 mark 12 Dantrolene sodium in malignant hyperthermia 2023 March (Supplementary) (2010 Scheme) Short Answer · 1 mark 13 d-Tubocurarine 2021 May (Supplementary) (2010 Scheme) Short Answer · 1 mark 14 Dantrolene in malignant hyperthermia. 2025 August (Supplementary) (2010 Scheme) Short Answer · 1 mark 15 Diazepam 2024 March (Supplementary) (2010 Scheme) Short Answer · 1 mark 16 Peripherally acting skeletal muscle relaxants 2013 September (Supplementary) (2010 Scheme) Short Answer · 1 mark 17 Uses of diazepam 2017 February (2010 Scheme) Short Answer · 1 mark 18 Competitive neuromuscular blockers 2018 July (Supplementary) (2010 Scheme) Short Answer · 1 mark 19 Dantrolene in malignant hyperthermia 2019 February (2010 Scheme) Short Answer · 1 mark 20 Centrally acting skeletal muscle relaxants 2022 May (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 21 Skeletal muscle relaxants 2022 July (Supplementary) (2019 Scheme) Short Answer · 0.2 marks 22 Centrally acting skeletal muscle relaxants 2024 March (Supplementary) (2019 Scheme) Short Answer · 0.2 marks